Guardant Health, Inc.

For the period ended Dec 31, 2025. Filed Feb 19, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 19, 2026

GH$155.35-2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders' Equity (Deficit)

(in thousands, except share data)

Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Equity (Deficit)
Shares · Amount · Treasury Stock
Balance as of January 1, 2023	102,619,383	$1	$—	$1,742,114	$(19,522)	$(1,662,413)	$60,180
Issuance of common stock upon follow-on offering, net of offering costs of $21,131	14,375,000	—	—	381,369	—	—	381,369
Issuance of common stock upon registered direct offering	3,387,446	—	—	90,616	—	—	90,616
Issuance of common stock upon exercise of stock options	51,124	—	—	405	—	—	405
Vesting of restricted stock units	732,038	—	—	—	—	—	—
Issuance of common stock under employee stock purchase plan	464,870	—	—	10,154	—	—	10,154
Employee taxes paid related to net share settlement of restricted stock units	—	—	—	(11,197)	—	—	(11,197)
Stock-based compensation	—	—	—	90,759	—	—	90,759
Other comprehensive income	—	—	—	—	15,847	—	15,847
Net loss	—	—	—	—	—	(479,449)	(479,449)
Balance as of December 31, 2023	121,629,861	1	—	2,304,220	(3,675)	(2,141,862)	158,684
Issuance of common stock upon exercise of stock options	609,495	—	—	3,119	—	—	3,119
Vesting of restricted stock units	1,176,892	—	—	—	—	—	—
Issuance of common stock under employee stock purchase plan	577,758	—	—	11,719	—	—	11,719
Employee taxes paid related to net share settlement of restricted stock units	—	—	—	(15,681)	—	—	(15,681)
Stock-based compensation	—	—	—	140,411	—	—	140,411
Other comprehensive loss	—	—	—	—	(1,526)	—	(1,526)
Net loss	—	—	—	—	—	(436,373)	(436,373)
Balance as of December 31, 2024	123,994,006	1	—	2,443,788	(5,201)	(2,578,235)	(139,647)
Issuance of common stock upon follow-on public offering, net of offering costs of $17,668	2,856,981	—	—	239,460	—	—	239,460
Repurchase of treasury stock	(976,351)	—	(45,010)	—	—	—	(45,010)
Reissuance of treasury stock upon follow-on public offering	976,351	—	45,010	42,862	—	—	87,872
Issuance of common stock upon exercise of stock options	627,325	—	—	19,223	—	—	19,223
Vesting of restricted stock units	2,674,890	—	—	—	—	—	—
Issuance of common stock under employee stock purchase plan	482,099	—	—	13,585	—	—	13,585
Employee taxes paid related to net share settlement of restricted stock units	—	—	—	(30,535)	—	—	(30,535)
Stock-based compensation	—	—	—	166,217	—	—	166,217
Unwinding of convertible note hedges	—	—	—	5,456	—	—	5,456
Other comprehensive income	—	—	—	—	349	—	349
Net loss	—	—	—	—	—	(416,277)	(416,277)
Balance as of December 31, 2025	130,635,301	$1	$—	$2,900,056	$(4,852)	$(2,994,512)	$(99,307)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.